Prescription drug costs

FILE - In this Tuesday, July 16, 2019, file photo, Health and Human Services Secretary Alex Azar pauses while speaking during a Cabinet meeting at the White House, in Washington. Azar says he and President Donald Trump are working on a plan to allow Americans to import lower-priced prescription drugs from Canada. (AP Photo/Alex Brandon, File)
July 31, 2019 - 6:41 am
WASHINGTON (AP) — The Trump administration is working on a plan that would allow Americans to import lower-priced prescription drugs from Canada, Health and Human Services Secretary Alex Azar says. Azar made his comments on Tuesday during an interview with CNBC, saying he had just gotten off the...
Read More
FILE - In this Wednesday, July 10, 2019, file photo, President Donald Trump speaks about kidney health, accompanied by Health and Human Services Secretary Alex Azar, left, in Washington. Azar says he and Trump are working on a plan to allow Americans to import lower-priced prescription drugs from Canada. (AP Photo/Alex Brandon, File)
July 31, 2019 - 12:44 am
WASHINGTON (AP) — The Trump administration is working on a plan that would allow Americans to import lower-priced prescription drugs from Canada, Health and Human Services Secretary Alex Azar said Tuesday. Azar made his comments during an interview with CNBC, saying he had just gotten off the phone...
Read More
FILE - This May 1, 2018 file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co. reports earnings Friday, Feb. 1, 2019. Merck & Co., Inc. reports financial results on Tuesday, July 30, 2019. (AP Photo/Seth Wenig, File)
July 30, 2019 - 2:31 pm
Soaring sales of its cancer blockbuster and vaccines helped drive Merck's second-quarter profit up a whopping 54%, blowing past Wall Street expectations. The maker of cancer immunotherapy drug Keytruda and diabetes pill Januvia also benefited from slightly reduced spending on research and...
Read More
FILE - In this June 18, 2019, file photo, U.S. Trade Representative Robert Lighthizer testifies before the Senate Finance Committee on Capitol Hill in Washington. Congressional Democrats appear to be moving from “no way’’ to “maybe’’ on President Donald Trump’s rewrite of a trade pact with Canada and Mexico. House Democrats have met four times with Lighthizer, most recently on Friday, July 26, and both sides say they are making progress toward a deal that would clear the way for Congress to approve Trump’s U.S.-Mexico-Canada Agreement, or USMCA. (AP Photo/Susan Walsh, File)
July 30, 2019 - 12:30 am
WASHINGTON (AP) — Congressional Democrats appear to be moving from "no way" to "maybe" on President Donald Trump's rewrite of a trade pact with Canada and Mexico. House Democrats have met four times with U.S. Trade Representative Robert Lighthizer, most recently on Friday, and both sides say they...
Read More
FILE - In this July 8, 2016, file photo, a prescription is filled at Pucci's Pharmacy in Sacramento, Calif. Four pharmaceutical companies are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high. California Attorney General Xavier Becerra said Monday, July 29, 2019, that the bulk of the money will come from Teva Pharmaceutical Industries for paying to delay a generic narcolepsy drug from entering the market for nearly six years. (AP Photo/Rich Pedroncelli, File)
July 29, 2019 - 6:47 pm
SACRAMENTO, Calif. (AP) — Three pharmaceutical companies collectively are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high, California Attorney General Xavier Becerra said Monday. The bulk of the money will come from Teva Pharmaceutical...
Read More
FILE - In this Sept. 21, 2016, file photo EpiPens that Mylan CEO Heather Bresch bought with her are seen on Capitol Hill in Washington as she testifies before the House Oversight Committee hearing on EpiPen price increases. Pfizer, the country's largest drugmaker, will absorb the generic pharmaceutical company Mylan, potentially creating a global generic powerhouse, the two companies said Monday, July 29, 2019. (AP Photo/Pablo Martinez Monsivais, File)
July 29, 2019 - 5:48 pm
Pfizer, the country's largest drugmaker, is creating a hybrid new drug company by combining its off-patent branded drug business with the generic pharmaceutical company Mylan. Pfizer's Upjohn, which sells one-time blockbusters like Viagra and Lipitor that have lost patent protection, will be spun...
Read More
FILE - In this July 8, 2016, file photo, a prescription is filled at Pucci's Pharmacy in Sacramento, Calif. Four pharmaceutical companies are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high. California Attorney General Xavier Becerra said Monday, July 29, 2019, that the bulk of the money will come from Teva Pharmaceutical Industries for paying to delay a generic narcolepsy drug from entering the market for nearly six years. (AP Photo/Rich Pedroncelli, File)
July 29, 2019 - 4:26 pm
SACRAMENTO, Calif. (AP) — Four pharmaceutical companies collectively are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high, California Attorney General Xavier Becerra said Monday. The bulk of the money will come from Teva Pharmaceutical...
Read More
FILE - In this July 8, 2016, file photo, a prescription is filled at Pucci's Pharmacy in Sacramento, Calif. Four pharmaceutical companies are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high. California Attorney General Xavier Becerra said Monday, July 29, 2019, that the bulk of the money will come from Teva Pharmaceutical Industries for paying to delay a generic narcolepsy drug from entering the market for nearly six years. (AP Photo/Rich Pedroncelli, File)
July 29, 2019 - 3:59 pm
SACRAMENTO, Calif. (AP) — Four pharmaceutical companies collectively are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high, California Attorney General Xavier Becerra said Monday. The bulk of the money will come from Teva Pharmaceutical...
Read More
FILE - In this Sept. 21, 2016, file photo EpiPens that Mylan CEO Heather Bresch bought with her are seen on Capitol Hill in Washington as she testifies before the House Oversight Committee hearing on EpiPen price increases. Pfizer, the country's largest drugmaker, will absorb the generic pharmaceutical company Mylan, potentially creating a global generic powerhouse, the two companies said Monday, July 29, 2019. (AP Photo/Pablo Martinez Monsivais, File)
July 29, 2019 - 11:56 am
Pfizer, the country's largest drugmaker, is creating a hybrid new drug company by combining its off-patent branded drug business with the generic pharmaceutical company Mylan. Pfizer's Upjohn, which sells one-time blockbusters like Viagra and Lipitor that have lost patent protection, will be spun...
Read More
FILE - In this Sept. 21, 2016, file photo EpiPens that Mylan CEO Heather Bresch bought with her are seen on Capitol Hill in Washington as she testifies before the House Oversight Committee hearing on EpiPen price increases. Pfizer, the country's largest drugmaker, will absorb the generic pharmaceutical company Mylan, potentially creating a global generic powerhouse, the two companies said Monday, July 29, 2019. (AP Photo/Pablo Martinez Monsivais, File)
July 29, 2019 - 10:49 am
Pfizer, the country's largest drugmaker, is creating a hybrid new drug company by combining its off-patent branded drug business with the generic pharmaceutical company Mylan. The two companies said Monday that they'll ultimately spin off the combination of Mylan, a $10 billion company, with Pfizer...
Read More

Pages